OS THERAPIES

Lobbying client · New York · filed 2025 to 2026

biotechnology company

$0 Reported spend

5 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 5 filings. Everything on this page is grouped by the client's LDA id (69263), not by name.

Firms hired 1

CHAMBER HILL STRATEGIES $0 5 filings

Reported by year 2 years

2026 $0 2 filings
2025 $0 3 filings

Issues lobbied 2

Health Issues 5
Pharmacy 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 4

Food & Drug Administration (FDA) 4
Health & Human Services, Dept of (HHS) 4
HOUSE OF REPRESENTATIVES 4
SENATE 4

Recent filings 5 total

Q2

CHAMBER HILL STRATEGIES

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · posted Jul 19, 2026

View → Q1

CHAMBER HILL STRATEGIES

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · posted Apr 6, 2026

View → Q4

CHAMBER HILL STRATEGIES

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · posted Jan 20, 2026

View → Q3

CHAMBER HILL STRATEGIES

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · posted Oct 17, 2025

View → RR

CHAMBER HILL STRATEGIES

3rd Quarter (July 1 - Sep 30) 2025 · posted Oct 16, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.